Joe Herring of Covance Elected 2011 ACRO Chair
February 7, 2011- WASHINGTON, D.C. – The Association of Clinical Research Organizations (ACRO), which represents the global clinicaloutsourcing industry to regulators, biopharmaceutical clients, policy makersand the public, today announced its Board of Directors has elected Joe Herring,Chairman and Chief Executive Officer of Covance Inc., as its 2011 Chair.
Mr. Herring joined Covance in 1996 after spending 18 years in a variety ofsenior positions in the healthcare services field. He became a member of theCovance board in 2004, assumed the role of Chief Executive Officer in 2005, andhas been Chairman of the Board since 2006. He is a graduate of Louisiana State University.Covance, headquartered in Princeton, NJ, is one of the world’s largestand most comprehensive drug development services companies with operations onmore than 30 countries and more than 10,000 employees worldwide.
“ACRO will continue toadvocate for the global CRO industry and promote the important role CROs play inthe development of safe and better medicines, said Mr. Herring. “In addition,we are committed to demonstrating and communicating the value of our industryto key stakeholders and finding ways to improve the drug development process.”
“Under Joe’sleadership, and with a committed membership that includes nine of the top 10CROs in the world, ACRO is well-positioned to play a major role in influencingpolicies and business practices that support outsourcing and lead to a moreefficient drug development enterprise,” said Doug Peddicord, Ph.D., ACROExecutive Director.
About ACRO
The Association of Clinical ResearchOrganizations (ACRO) represents companies whose focus is clinical research. Theassociation provides an active voice for the global CRO industry, whichprovides specialized services that are integral to the development of drugs,biologics and medical devices. Through its member companies, ACRO helps improvethe quality, efficiency and safety of biomedical research. ACRO membercompanies employ approximately 70,000 professionals worldwide and annuallyconduct more than 9,000 clinical trials involving nearly 2 million participantsin 115 countries. For more information, please visit www.www.acrohealth.org.